Treatment of Tinea Versicolor
Topical ketoconazole 2% cream or shampoo is the first-line treatment for tinea versicolor, with oral antifungals reserved for extensive disease or when topical treatments fail. 1, 2
Treatment Algorithm
First-Line Treatment: Topical Therapy
- Ketoconazole 2% cream: Apply once daily to affected and surrounding areas for two weeks 1
- Ketoconazole 2% shampoo:
- Other effective topical options:
- Selenium sulfide 1% shampoo
- Zinc pyrithione
- Terbinafine cream 2
Second-Line Treatment: Oral Therapy
For extensive disease, recalcitrant cases, or when topical treatments fail:
- Fluconazole: 300 mg once weekly for 2 weeks 4
- Itraconazole: 200 mg daily for 5-7 days 4
- Pramiconazole: 200 mg daily for 2 days (newer option) 4
Important note: Oral terbinafine is NOT effective for tinea versicolor despite its efficacy in other fungal infections 2, 5
Clinical Considerations
Diagnosis
- Clinical appearance: Hypopigmented or hyperpigmented macules with fine scale
- Confirmation: KOH preparation showing "spaghetti and meatballs" appearance (hyphae and yeast cells)
- Causative organism: Malassezia furfur (previously known as Pityrosporum orbiculare) 1
Treatment Pitfalls
High recurrence rate: Tinea versicolor has a high recurrence rate even after successful treatment 6
- Follow-up is essential to confirm mycological cure, not just clinical improvement
- Consider maintenance therapy for recurrent cases
Ineffective treatments:
Delayed clinical response:
- Pigmentary changes may persist for weeks to months after successful treatment
- Patients should be counseled that skin color normalization may take time despite mycological cure
Special Populations
- Extensive disease: Oral therapy is preferred over topical treatments
- Recurrent cases: Consider prophylactic therapy with intermittent topical applications
- Immunocompromised patients: May require longer treatment courses and closer follow-up
Evidence Quality
The recommendations are based primarily on the FDA-approved indications for ketoconazole cream 1 and systematic reviews of antifungal treatments for tinea versicolor 2, 4. The evidence for oral antifungal dosing regimens is particularly strong, with the 2014 systematic review evaluating 57 trials to determine optimal dosing 4.